# Reducing Acute Kidney Injury Occurence by Administering Angiotensin II

> **NCT05199493** · PHASE3 · COMPLETED · sponsor: **Universität Münster** · enrollment: 64 (actual)

## Conditions studied

- Cardiac Surgery
- Vasoplegia
- Hyperreninemia

## Interventions

- **DRUG:** Angiotensin II
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT05199493
- **Lead sponsor:** Universität Münster
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-27
- **Primary completion:** 2022-12-19
- **Final completion:** 2023-03-19
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2023-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05199493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05199493, "Reducing Acute Kidney Injury Occurence by Administering Angiotensin II". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05199493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*